DSS.AMEXDss, INC

Form 4: DSS Inc. Amends IBO Stock Ownership Filing

Sentiment:

Insider Transaction Report Amendment

📋All filings for Dss, INC
🔒Login to Follow

DSS Inc. filed an amended Form 4 to correct its beneficial ownership of IMPACT BIOMEDICAL INC. common stock, now totaling 545,024 shares.

Summary

  • DSS, INC., a 10% owner and director of IMPACT BIOMEDICAL INC. (IBO), filed an amendment to a previously submitted Form 4.
  • The amendment corrects an error in the total number of IBO common stock shares beneficially owned by DSS, INC. from its original filing on May 27, 2025.
  • On May 22, 2025, DSS, INC. disposed of 115,600 shares of IBO Common Stock at a price of $0.5491 per share.
  • On May 27, 2025, DSS, INC. disposed of an additional 45,400 shares of IBO Common Stock at a price of $0.5403 per share.
  • Following these transactions and the correction, DSS, INC. beneficially owns a total of 545,024 shares of IBO's common stock.
  • The corrected beneficial ownership figure includes shares acquired pursuant to the Celios Asset sale.

Sentiment

Score: 5

Explanation: Neutral. The filing is an amendment to correct beneficial ownership and reports insider sales. It does not provide operational or financial performance insights that would significantly alter a fundamental view of the company.

Negatives

  • DSS, INC., a significant 10% owner, disposed of a total of 161,000 shares of IMPACT BIOMEDICAL INC. common stock across two transactions.
  • The necessity of filing an amendment to correct a previously reported beneficial ownership figure indicates an initial reporting error.

Risks

  • A reduction in stake by a 10% owner could be interpreted by the market as a signal of reduced confidence in the company's future prospects, potentially impacting investor sentiment.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing is a standard insider transaction report and does not provide information to analyze broader industry trends or competitive positioning.

Stakeholder Impact

  • Shareholders: The disposition of shares by a 10% owner could be viewed as a signal regarding the company's prospects, potentially influencing investor sentiment.

Key Dates

DateDescription
05/22/2025Transaction date for the disposition of 115,600 shares of Common Stock by DSS, INC.
05/27/2025Transaction date for the disposition of 45,400 shares of Common Stock by DSS, INC.
05/27/2025Date of the original Form 4 filing that contained an error in beneficial ownership.
01/06/2026Date the amendment was signed by the reporting person, Jason Grady.

Keywords

SEC Form 4, beneficial ownership, insider transaction, stock sale, IMPACT BIOMEDICAL INC., IBO, DSS INC., Celios Asset sale

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.